Table of Contents Author Guidelines Submit a Manuscript
Veterinary Medicine International
Volume 2014 (2014), Article ID 789353, 7 pages
http://dx.doi.org/10.1155/2014/789353
Research Article

A Population Pharmacokinetic Approach to Describe Cephalexin Disposition in Adult and Aged Dogs

1Farmacología, Facultad de Ciencias Veterinarias, Universidad de Buenos Aires. Chorroarín 280, 1427 Buenos Aires, Argentina
2Unidad de Farmacocinética Clínica-CONICET, Hospital de Pediatría JP Garrahan, Combate de los Pozos 1881, 1245 Buenos Aires, Argentina

Received 8 July 2014; Accepted 9 October 2014; Published 6 November 2014

Academic Editor: Guillermo Virkel

Copyright © 2014 Ana Paula Prados et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. G. L. Drusano, “Antimicrobial pharmacodynamics: critical interactions of “bug and drug”,” Nature Reviews Microbiology, vol. 2, no. 4, pp. 289–300, 2004. View at Publisher · View at Google Scholar · View at Scopus
  2. P. L. Toutain, J. R. E. del Castillo, and A. Bousquet-Mélou, “The pharmacokinetic-pharmacodynamic approach to a rational dosage regimen for antibiotics,” Research in Veterinary Science, vol. 73, no. 2, pp. 105–114, 2002. View at Publisher · View at Google Scholar · View at Scopus
  3. P. M. Dowling, “Geriatric pharmacology,” Veterinary Clinics of North America: Small Animal Practice, vol. 35, no. 3, pp. 557–569, 2005. View at Publisher · View at Google Scholar · View at Scopus
  4. A. J. McLean and D. G. le Couteur, “Aging biology and geriatric clinical pharmacology,” Pharmacological Reviews, vol. 56, no. 2, pp. 163–184, 2004. View at Publisher · View at Google Scholar · View at Scopus
  5. S. Modric and M. Martinez, “Patient variation in veterinary medicine—Part II: influence of physiological variables,” Journal of Veterinary Pharmacology and Therapeutics, vol. 34, no. 3, pp. 209–223, 2011. View at Publisher · View at Google Scholar · View at Scopus
  6. D. M. Boothe, “Factors affecting drug disposition,” in Small Animal Clinical Pharmacology & Therapeutics, D. M. Boothe, Ed., pp. 34–47, 2012. View at Google Scholar
  7. B. G. Campbell and E. Rosin, “Effect of food on absorption of cefadroxil and cephalexin in dogs,” Journal of Veterinary Pharmacology and Therapeutics, vol. 21, no. 5, pp. 418–420, 1998. View at Publisher · View at Google Scholar · View at Scopus
  8. A. Chicoine, W. Cox, L. Huang, G. Wang, and P. Dowling, “Bioavailability and pharmacokinetics of a novel cephalexin oral paste formulation in fed and fasted dogs,” Journal of Veterinary Pharmacology and Therapeutics, vol. 32, no. 4, pp. 400–402, 2009. View at Publisher · View at Google Scholar · View at Scopus
  9. A. P. Prados, V. Kreil, G. Albarellos, S. Waxman, and M. Rebuelto, “Metoclopramide modifies oral cephalexin pharmacokinetics in dogs,” Journal of Veterinary Pharmacology and Therapeutics, vol. 30, no. 2, pp. 127–131, 2007. View at Publisher · View at Google Scholar · View at Scopus
  10. A. P. Prados, V. Kreil, L. Tarragona, P. Quaine, A. Monfrinotti, and M. Rebuelto, “El Meloxicam no modifica la disposición de la cefalexina en caninos,” InVet, vol. 10, no. 1, pp. 19–25, 2008 (Spanish). View at Google Scholar
  11. A. P. Prados, L. Ambros, L. Montoya, and M. Rebuelto, “Chronopharmacological study of cephalexin in dogs,” Chronobiology International, vol. 24, no. 1, pp. 161–170, 2007. View at Publisher · View at Google Scholar · View at Scopus
  12. S. Carli, P. Anfossi, R. Villa, G. Castellani, G. Mengozzi, and C. Montesissa, “Absorption kinetics and bioavailability of cephalexin in the dog after oral and intramuscular administration,” Journal of Veterinary Pharmacology and Therapeutics, vol. 22, no. 5, pp. 308–313, 1999. View at Publisher · View at Google Scholar · View at Scopus
  13. T. Martín-Jiménez and J. E. Riviere, “Population pharmacokinetics in veterinary medicine: potential use for therapeutic drug monitoring and prediction of tissue residues,” Journal of Veterinary Pharmacology and Therapeutics, vol. 21, no. 3, pp. 167–189, 1998. View at Publisher · View at Google Scholar · View at Scopus
  14. M. Estudante, J. G. Morais, G. Soveral, and L. Z. Benet, “Intestinal drug transporters: an overview,” Advanced Drug Delivery Reviews, vol. 65, no. 10, pp. 1340–1356, 2013. View at Publisher · View at Google Scholar · View at Scopus
  15. X.-Y. Chu, G. P. Sánchez-Castaño, K. Higaki, D.-M. Oh, C.-P. Hsu, and G. L. Amidon, “Correlation between epithelial cell permeability of cephalexin and expression of intestinal oligopeptide transporter,” Journal of Pharmacology and Experimental Therapeutics, vol. 299, no. 2, pp. 575–582, 2001. View at Google Scholar · View at Scopus
  16. K. Mitsuoka, Y. Kato, Y. Kubo, and A. Tsuji, “Functional expression of stereoselective metabolism of cephalexin by exogenous transfection of oligopeptide transporter PEPT1,” Drug Metabolism and Disposition, vol. 35, no. 3, pp. 356–362, 2007. View at Publisher · View at Google Scholar · View at Scopus
  17. M. Buyse, F. Berlioz, S. Guilmeau et al., “PepT1-mediated epithelial transport of dipeptides and cephalexin is enhanced by luminal leptin in the small intestine,” Journal of Clinical Investigation, vol. 108, no. 10, pp. 1483–1494, 2001. View at Publisher · View at Google Scholar · View at Scopus
  18. H.-Q. Chen, T.-Y. Shen, Y.-K. Zhou et al., “Lactobacillus plantarum consumption increases PepT1-mediated amino acid absorption by enhancing protein kinase C activity in spontaneously colitic mice,” The Journal of Nutrition, vol. 140, no. 12, pp. 2201–2206, 2010. View at Publisher · View at Google Scholar · View at Scopus
  19. N. G. Nerella, L. H. Block, and P. K. Noonan, “The impact of lag time on the estimation of pharmacokinetic parameters. I. One-compartment open model,” Pharmaceutical Research, vol. 10, no. 7, pp. 1031–1036, 1993. View at Publisher · View at Google Scholar · View at Scopus
  20. M. Rebuelto, L. Montoya, A. P. Prados et al., “Lack of interaction of metoclopramide on oral amoxicillin kinetics in dogs,” Journal of Veterinary Pharmacology and Therapeutics, vol. 34, no. 6, pp. 621–624, 2011. View at Publisher · View at Google Scholar · View at Scopus
  21. S. Wamberg, N. C. Sandgaard, and P. Bie, “Simultaneous determination of total body water and plasma volume in conscious dogs by the indicator dilution principle,” Journal of Nutrition, vol. 132, supplement 2, no. 6, pp. 1711S–1713S, 2002. View at Google Scholar · View at Scopus
  22. J. R. Speakman, A. van Acker, and E. J. Harper, “Age-related changes in the metabolism and body composition of three dog breeds and their relationship to life expectancy,” Aging Cell, vol. 2, no. 5, pp. 265–275, 2003. View at Publisher · View at Google Scholar
  23. I. Jeusette, D. Greco, F. Aquino et al., “Effect of breed on body composition and comparison between various methods to estimate body composition in dogs,” Research in Veterinary Science, vol. 88, no. 2, pp. 227–232, 2010. View at Publisher · View at Google Scholar · View at Scopus
  24. L. G. Downs, C. H. Bolton, S. M. Crispin, and J. M. Wills, “Plasma lipoprotein lipids in five different breeds of dogs,” Research in Veterinary Science, vol. 54, no. 1, pp. 63–67, 1993. View at Publisher · View at Google Scholar · View at Scopus
  25. M. G. Papich, J. L. Davis, and A. M. Floerchinger, “Pharmacokinetics, protein binding, and tissue distribution of orally administered cefpodoxime proxetil and cephalexin in dogs,” The American Journal of Veterinary Research, vol. 71, no. 12, pp. 1484–1491, 2010. View at Publisher · View at Google Scholar · View at Scopus
  26. S.-H. Lee, J.-L. Ghim, M.-H. Song et al., “Pharmacokinetics and pharmacodynamics of a new reformulated microemulsion and the long-chain triglyceride emulsion of propofol in beagle dogs,” British Journal of Pharmacology, vol. 158, no. 8, pp. 1982–1995, 2009. View at Publisher · View at Google Scholar · View at Scopus
  27. S. C. N. Buist, N. J. Cherrington, S. Choudhuri, D. P. Hartley, and C. D. Klaassen, “Gender-specific and developmental influences on the expression of rat organic anion transporters,” Journal of Pharmacology and Experimental Therapeutics, vol. 301, no. 1, pp. 145–151, 2002. View at Publisher · View at Google Scholar · View at Scopus
  28. M. Ljubojević, D. Balen, D. Breljak et al., “Renal expression of organic anion transporter OAT2 in rats and mice is regulated by sex hormones,” American Journal of Physiology: Renal Physiology, vol. 292, no. 1, pp. F361–F372, 2007. View at Publisher · View at Google Scholar · View at Scopus
  29. I. Sabolić, A. R. Asif, W. E. Budach, C. Wanke, A. Bahn, and G. Burckhardt, “Gender differences in kidney function,” Pflugers Archiv European Journal of Physiology, vol. 455, no. 3, pp. 397–429, 2007. View at Publisher · View at Google Scholar · View at Scopus
  30. C. E. Groves, W. B. Suhre, N. J. Cherrington, and S. H. Wright, “Sex differences in the mRNA, protein, and functional expression of organic anion transporter (Oat) 1, Oat3, and organic cation transporter (Oct) 2 in rabbit renal proximal tubules,” The Journal of Pharmacology and Experimental Therapeutics, vol. 316, no. 2, pp. 743–752, 2006. View at Publisher · View at Google Scholar · View at Scopus